Cargando…
Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment
For cutaneous squamous cell carcinoma (cSCC), topical treatment is an essential option for patients who are not candidates for, or who refuse, surgery. Epidermal growth factor receptor (EGFR) plays a key role in the development of cSCC, but EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib,...
Autores principales: | Inoue, Jun, Fujiwara, Kyoko, Hamamoto, Hidetoshi, Kobayashi, Katsunori, Inazawa, Johji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695908/ https://www.ncbi.nlm.nih.gov/pubmed/33294587 http://dx.doi.org/10.1016/j.omto.2020.10.009 |
Ejemplares similares
-
Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer
por: Kishikawa, Masahiro, et al.
Publicado: (2021) -
Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy
por: Gokita, Kentaro, et al.
Publicado: (2019) -
Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma
por: Tran, Phuong Xuan, et al.
Publicado: (2022) -
Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma
por: Sakha, Sujata, et al.
Publicado: (2016) -
Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection
por: Okuda, Masafumi, et al.
Publicado: (2017)